Clinical Trial Update: An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update assesses the safety and utility of Treximet (sumatriptan/naproxen) for the treatment of menstrual migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menstrual Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Menstrual Migraine | Phase 4 | Status: COMPLETED